drugset
Drugs / bivalent oral poliovirus vaccine
last change Jul 2020 re-read 2 minutes ago

bivalent oral poliovirus vaccine

also known as bOPV

Vaccine

Investigated by
China National Biotec Group Company Limited · Hubei Provincial Center for Disease Control and Prevention · Inner Mongolia Autonomous Region Center for Diseases Prevention and Control · Peking University · Shaanxi Provincial Center for Disease Control and Prevention

Trials 1 · a red edge is where a trial was stopped

today NCT04054492 · Ph 4
201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04054492 Mar 2018 → Jan 2019 — China National Biotec Group Company Limited Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as bivalent oral poliovirus vaccine “bivalent oral poliovirus vaccine (bOPV)” PMID 32747216 ↗ Jul 2020
Known as bOPV ClinicalTrials.gov intervention name — accepted as the source's own label NCT04054492 ↗
Modality Vaccine “bivalent oral poliovirus vaccine (bOPV)” PMID 32747216 ↗ Jul 2020